Brain organic cation transporter 2 controls response and vulnerability to stress and GSK3β signaling

Molecular Psychiatry

Volumn 20, Issue 7, 2015, Pages 889-900

  Courousse T ^a,b,c   Bacq, A ^a,b,h   Belzung, C ^d   Guiard, B ^e   Balasse, L ^a,b   Louis, F ^a,b   Le Guisquet, A M ^d   Gardier, A M ^e   Schinkel, A H ^f   Giros, B ^a,b,g   Gautron, S ^a,b  

^a and Centre National de la Recherche Scientifique Unité Mixte de Recherche 8246   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d Université de Tours   (France)

^e University of Paris XI   (France)

^f NETHERLANDS CANCER INSTITUTE   (Netherlands)

^g DOUGLAS MENTAL HEALTH UNIVERSITY INSTITUTE   (Canada)

^h EPFL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTERONE; CORTICOTROPIN; GLYCOGEN SYNTHASE KINASE 3BETA; ORGANIC CATION TRANSPORTER 2; PROTEIN KINASE B; SEROTONIN; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; HORMONE; NORADRENALIN; ORGANIC CATION TRANSPORTER; SLC22A2 PROTEIN, MOUSE;

ACUTE STRESS; ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; COMPARATIVE STUDY; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CORTICOSTERONE RELEASE; ENVIRONMENTAL FACTOR; GENE DELETION; HORMONE RESPONSE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; MOUSE; NESTING; NONHUMAN; PRIORITY JOURNAL; SELF CARE; SIGNAL TRANSDUCTION; SOCIAL BEHAVIOR; SOCIAL INTERACTION; SPATIAL MEMORY; STRESS VULNERABILITY; WESTERN BLOTTING; WILD TYPE; ACTION POTENTIAL; ACUTE DISEASE; ANIMAL; BRAIN; C57BL MOUSE; CHRONIC DISEASE; COPING BEHAVIOR; DEPRESSION; DRUG EFFECTS; GENETICS; KNOCKOUT MOUSE; MENTAL STRESS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PYRAMIDAL NERVE CELL; UNCERTAINTY;

ACTION POTENTIALS; ACUTE DISEASE; ANIMALS; BRAIN; CHRONIC DISEASE; CORTICOSTERONE; DEPRESSION; GLYCOGEN SYNTHASE KINASE 3; HORMONES; MALE; MICE, INBRED C57BL; MICE, KNOCKOUT; NOREPINEPHRINE; ORGANIC CATION TRANSPORT PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; PYRAMIDAL CELLS; RESILIENCE, PSYCHOLOGICAL; SEROTONIN; STRESS, PSYCHOLOGICAL; UNCERTAINTY;

EID: 84932200102     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2014.86     Document Type: Article

References (70)

1. Wong ML, Licinio J. Research and treatment approaches to depression. Nat Rev Neurosci 2001; 2: 343-351
2. Krishnan V, Nestler EJ. The molecular neurobiology of depression. Nature 2008; 455: 894-902
3. Caspi A, Hariri AR, Holmes A, Uher R, Moffitt TE. Genetic sensitivity to the environment: the case of the serotonin transporter gene and its implications for studying complex diseases and traits. Am J Psychiatry 2010; 167: 509-527
4. Mazure CM, Bruce ML, Maciejewski PK, Jacobs SC. Adverse life events and cognitive-personality characteristics in the prediction of major depression and antidepressant response. Am J Psychiatry 2000; 157: 896-903
5. Lupien SJ, McEwen BS, Gunnar MR, Heim C. Effects of stress throughout the lifespan on the brain, behaviour and cognition. Nat Rev Neurosci 2009; 10: 434-445
6. Herbert J. Cortisol and depression: three questions for psychiatry. Psychol Med 2013; 43: 449-469
7. Ulrich-Lai YM, Herman JP. Neural regulation of endocrine and autonomic stress responses. Nat Rev Neurosci 2009; 10: 397-409
8. Ziegler DR, Herman JP. Neurocircuitry of stress integration: anatomical pathways regulating the hypothalamo-pituitary-Adrenocortical axis of the rat. Integr Comp Biol 2002; 42: 541-551
9. Kvetnansky R, Sabban EL, Palkovits M. Catecholaminergic systems in stress: structural and molecular genetic approaches. Physiol Rev 2009; 89: 535-606
10. Vialou V, Balasse L, Callebert J, Launay JM, Giros B, Gautron S. Altered aminergic neurotransmission in the brain of organic cation transporter 3-deficient mice. J Neurochem 2008; 106: 1471-1482
11. Bacq A, Balasse L, Biala G, Guiard B, Gardier AM, Schinkel A, et al. Organic cation transporter 2 controls brain norepinephrine and serotonin clearance and antidepressant response. Mol Psychiatry 2012; 17: 926-939
12. Horton RE, Apple DM, Owens WA, Baganz NL, Cano S, Mitchell NC, et al. Decynium-22 enhances SSRI-induced antidepressant-like effects in mice: uncovering novel targets to treat depression. J Neurosci 2013; 33: 10534-10543
13. Grundemann D, Schechinger B, Rappold GA, Schomig E. Molecular identification of the corticosterone-sensitive extraneuronal catecholamine transporter. Nat Neurosci 1998; 1: 349-351
14. Hayer-Zillgen M, Bruss M, Bonisch H. Expression and pharmacological profile of the human organic cation transporters hOCT1, hOCT2 and hOCT3. Br J Pharmacol 2002; 136: 829-836
15. Gasser PJ, Lowry CA, Orchinik M. Corticosterone-sensitive monoamine transport in the rat dorsomedial hypothalamus: potential role for organic cation transporter 3 in stress-induced modulation of monoaminergic neurotransmission. J Neurosci 2006; 26: 8758-8766
16. Baganz N, Horton R, Martin K, Holmes A, Daws LC. Repeated swim impairs serotonin clearance via a corticosterone-sensitive mechanism: organic cation transporter 3, the smoking gun. J Neurosci 2010; 30: 15185-15195
17. Jonker JW, Wagenaar E, Van Eijl S, Schinkel AH. Deficiency in the organic cation transporters 1 and 2 (Oct1/Oct2 [Slc22a1/Slc22a2]) in mice abolishes renal secretion of organic cations. Mol Cell Biol 2003; 23: 7902-7908
18. Nollet M, Le Guisquet AM, Belzung C. Models of depression: unpredictable chronic mild stress in mice. Curr Protoc Pharmacol 2013; Chapter 5: Unit 5 65
19. Surget A, Saxe M, Leman S, Ibarguen-Vargas Y, Chalon S, Griebel G, et al. Drugdependent requirement of hippocampal neurogenesis in a model of depression and of antidepressant reversal. Biol Psychiatry 2008; 64: 293-301
20. Guiard BP, El Mansari M, Blier P. Cross-Talk between dopaminergic and noradrenergic systems in the rat ventral tegmental area, locus ceruleus, and dorsal hippocampus. Mol Pharmacol 2008; 74: 1463-1475
21. David DJ, Bourin M, Jego G, Przybylski C, Jolliet P, Gardier AM. Effects of acute treatment with paroxetine, citalopram and venlafaxine in vivo on noradrenaline and serotonin outflow: a microdialysis study in Swiss mice. Br J Pharmacol 2003; 140: 1128-1136
22. Meller E, Li H, Carr KD, Hiller JM. 5-Hydroxytryptamine(1) receptor-stimulated [(35)S]GTPgammaS binding in rat brain: absence of regional differences in coupling efficiency. J Pharmacol Exp Ther 2000; 292: 684-691
23. Herman JP, Figueiredo H, Mueller NK, Ulrich-Lai Y, Ostrander MM, Choi DC, et al. Central mechanisms of stress integration: hierarchical circuitry controlling hypothalamo-pituitary-Adrenocortical responsiveness. Front Neuroendocrinol 2003; 24: 151-180
24. Nussdorfer GG. Paracrine control of adrenal cortical function by medullary chromaffin cells. Pharmacol Rev 1996; 48: 495-530
25. Brede M, Nagy G, Philipp M, Sorensen JB, Lohse MJ, Hein L. Differential control of adrenal and sympathetic catecholamine release by alpha 2-Adrenoceptor subtypes. Mol Endocrinol 2003; 17: 1640-1646
26. Rush AJ, Giles DE, Schlesser MA, Orsulak PJ, Parker Jr. C.R., Weissenburger JE, et al. The dexamethasone suppression test in patients with mood disorders. J Clin Psychiatry 1996; 57: 470-484
27. Gourley SL, Wu FJ, Kiraly DD, Ploski JE, Kedves AT, Duman RS, et al. Regionally specific regulation of ERK MAP kinase in a model of antidepressant-sensitive chronic depression. Biol Psychiatry 2008; 63: 353-359
28. Denmark A, Tien D, Wong K, Chung A, Cachat J, Goodspeed J, et al. The effects of chronic social defeat stress on mouse self-grooming behavior and its patterning. Behav Brain Res 2010; 208: 553-559
29. Bird CM, Burgess N. The hippocampus and memory: insights from spatial processing. Nat Rev Neurosci 2008; 9: 182-194
30. Deacon RM. Assessing nest building in mice. Nat Protoc 2006; 1: 1117-1119
31. Gobbi G, Murphy DL, Lesch K, Blier P. Modifications of the serotonergic system in mice lacking serotonin transporters: an in vivo electrophysiological study. J Pharmacol Exp Ther 2001; 296: 987-995
32. Cole AR. GSK3 as a sensor determining cell fate in the brain. Front Mol Neurosci 2012; 5: 4
33. Beaulieu JM, Zhang X, Rodriguiz RM, Sotnikova TD, Cools MJ, Wetsel WC, et al. Role of GSK3 beta in behavioral abnormalities induced by serotonin deficiency. Proc Natl Acad Sci USA 2008; 105: 1333-1338
34. Beaulieu JM, Gainetdinov RR, Caron MG. Akt/GSK3 signaling in the action of psychotropic drugs. Annu Rev Pharmacol Toxicol 2009; 49: 327-347
35. Li X, Zhu W, Roh MS, Friedman AB, Rosborough K, Jope RS. In vivo regulation of glycogen synthase kinase-3beta (GSK3bet) by serotonergic activity in mouse brain. Neuropsychopharmacology 2004; 29: 1426-1431
36. Frame S, Cohen P, Biondi RM A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation. Mol Cell 2001; 7: 1321-1327
37. Segal RA. Selectivity in neurotrophin signaling: theme and variations. Annu Rev Neurosci 2003; 26: 299-330
38. Tanaka KF, Samuels BA, Hen R. Serotonin receptor expression along the dorsalventral axis of mouse hippocampus. Philos Trans R Soc Lond Ser B 2012; 367: 2395-2401
39. Pariante CM, Lightman SL. The HPA axis in major depression: classical theories and new developments. Trends Neurosci 2008; 31: 464-468
40. Pitman RK, Rasmusson AM, Koenen KC, Shin LM, Orr SP, Gilbertson MW, et al. Biological studies of post-Traumatic stress disorder. Nat Rev Neurosci 2012; 13: 769-787
41. Elliott E, Ezra-Nevo G, Regev L, Neufeld-Cohen A, Chen A. Resilience to social stress coincides with functional DNA methylation of the Crf gene in adult mice. Nat Neurosci 2010; 13: 1351-1353
42. Russo SJ, Murrough JW, Han MH, Charney DS, Nestler EJ. Neurobiology of resilience. Nat Neurosci 2012; 15: 1475-1484
43. Marazziti D, Consoli G, Picchetti M, Carlini M, Faravelli L. Cognitive impairment in major depression. Eur J Pharmacol 2010; 626: 83-86
44. Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM. Neurobiology of depression. Neuron 2002; 34: 13-25
45. Nutt DJ. The psychobiology of posttraumatic stress disorder. J Clin Psychiatry 2000; 61(Suppl 5): 24-29; discussion 30-22
46. Bogdan R, Nikolova YS, Pizzagalli DA. Neurogenetics of depression: a focus on reward processing and stress sensitivity. Neurobiol Dis 2013; 52: 12-23
47. Busch AE, Karbach U, Miska D, Gorboulev V, Akhoundova A, Volk C, et al. Human neurons express the polyspecific cation transporter hOCT2, which translocates monoamine neurotransmitters, amantadine, and memantine. Mol Pharmacol 1998; 54: 342-352
48. Bangasser DA, Shors TJ. The hippocampus is necessary for enhancements and impairments of learning following stress. Nat Neurosci 2007; 10: 1401-1403
49. Wagner KV, Hartmann J, Mangold K, Wang XD, Labermaier C, Liebl C, et al. Homer1 mediates acute stress-induced cognitive deficits in the dorsal hippocampus. J Neurosci 2013; 33: 3857-3864
50. Kaouane N, Porte Y, Vallee M, Brayda-Bruno L, Mons N, Calandreau L, et al. Glucocorticoids can induce PTSD-like memory impairments in mice. Science 2012; 335: 1510-1513
51. de Quervain DJ, Roozendaal B, McGaugh JL. Stress and glucocorticoids impair retrieval of long-Term spatial memory. Nature 1998; 394: 787-790
52. Herman JP, Cullinan WE. Neurocircuitry of stress: central control of the hypothalamo-pituitary-Adrenocortical axis. Trends Neurosci 1997; 20: 78-84
53. Kaidanovich-Beilin O, Milman A, Weizman A, Pick CG, Eldar-Finkelman H. Rapid antidepressive-like activity of specific glycogen synthase kinase-3 inhibitor and its effect on beta-catenin in mouse hippocampus. Biol Psychiatry 2004; 55: 781-784
54. Polter A, Beurel E, Yang S, Garner R, Song L, Miller CA, et al. Deficiency in the inhibitory serine-phosphorylation of glycogen synthase kinase-3 increases sensitivity to mood disturbances. Neuropsychopharmacology 2010; 35: 1761-1774
55. O'Brien WT, Harper AD, Jove F, Woodgett JR, Maretto S, Piccolo S, et al. Glycogen synthase kinase-3beta haploinsufficiency mimics the behavioral and molecular effects of lithium. J Neurosci 2004; 24: 6791-6798
56. Beaulieu JM, Marion S, Rodriguiz RM, Medvedev IO, Sotnikova TD, Ghisi V, et al A beta-Arrestin 2 signaling complex mediates lithium action on behavior. Cell 2008; 132: 125-136
57. Polter AM, Li X. Glycogen synthase kinase-3 is an intermediate modulator of serotonin neurotransmission. Front Mol Neurosci 2011; 4: 31
58. Tsuji M, Takeda H, Matsumiya T. Protective effects of 5-HT1A receptor agonists against emotional changes produced by stress stimuli are related to their neuroendocrine effects. Br J Pharmacol 2001; 134: 585-595
59. Mikkelsen JD, Hay-Schmidt A, Kiss A. Serotonergic stimulation of the rat hypothalamo-pituitary-Adrenal axis: interaction between 5-HT1A and 5-HT2A receptors. Ann N Y Acad Sci 2004; 1018: 65-70
60. Hong JG, Kim DH, Lee CH, Park SJ, Kim JM, Cai M, et al. GSK-3beta activity in the hippocampus is required for memory retrieval. Neurobiol Learn Mem 2012; 98: 122-129
61. Kimura T, Yamashita S, Nakao S, Park JM, Murayama M, Mizoroki T, et al. GSK-3beta is required for memory reconsolidation in adult brain. PLoS One 2008; 3: e3540
62. Chen DY, Stern SA, Garcia-Osta A, Saunier-Rebori B, Pollonini G, Bambah-Mukku D, et al A critical role for IGF-II in memory consolidation and enhancement. Nature 2011; 469: 491-497
63. Peineau S, Taghibiglou C, Bradley C, Wong TP, Liu L, Lu J, et al. LTP inhibits LTD in the hippocampus via regulation of GSK3beta. Neuron 2007; 53: 703-717
64. Ge Y, Dong Z, Bagot RC, Howland JG, Phillips AG, Wong TP, et al. Hippocampal long-Term depression is required for the consolidation of spatial memory. Proc Natl Acad Sci USA 2010; 107: 16697-16702
65. Dong Z, Bai Y, Wu X, Li H, Gong B, Howland JG, et al. Hippocampal long-Term depression mediates spatial reversal learning in the Morris water maze. Neuropharmacology 2013; 64: 65-73
66. Latapy C, Rioux V, Guitton MJ, Beaulieu JM. Selective deletion of forebrain glycogen synthase kinase 3beta reveals a central role in serotoninsensitive anxiety and social behaviour. Philos Trans R Soc Lond Ser B 2012; 367: 2460-2474
67. Wilkinson MB, Dias C, Magida J, Mazei-Robison M, Lobo M, Kennedy P, et al A novel role of the WNT-dishevelled-GSK3beta signaling cascade in the mouse nucleus accumbens in a social defeat model of depression. J Neurosci 2011; 31: 9084-9092
68. Dahlhoff M, Siegmund A, Golub Y, Wolf E, Holsboer F, Wotjak CT. AKT/GSK-3beta/beta-catenin signalling within hippocampus and amygdala reflects genetically determined differences in posttraumatic stress disorder like symptoms. Neuroscience 2010; 169: 1216-1226
69. Takeda M, Khamdang S, Narikawa S, Kimura H, Kobayashi Y, Yamamoto T, et al. Human organic anion transporters and human organic cation transporters mediate renal antiviral transport. J Pharmacol Exp Ther 2002; 300: 918-924
70. Kimura N, Masuda S, Tanihara Y, Ueo H, Okuda M, Katsura T, et al. Metformin is a superior substrate for renal organic cation transporter OCT2 rather than hepatic OCT1. Drug Metab Pharmacokinet 2005; 20: 379-386